Mr Anil G Bhansali, founder chairman and MD, brings with him a rich experience of over four decades in the areas of Engineering, Infrastructure, and Research & Development of herbal based molecules to produce pre-cursors, APIs and Intermediates. Apart from R & D work on several other APIs and Intermediates, his key developments include the development of 10 DAB III for Dabur, Cipla and Dr. Reddy’s for production of Paclitaxel and Docetaxel. Since 2004, his main occupation has been to develop a formulation for Sickle Cell Anemia, which is now a commercial reality. Mr Anil Bhansali is also the Chairman and Chief Architect of Emerald Industries Ltd, with Emerald Industries being his flagship company, engaged in engineering, infrastructure and research.